Albert Ortiol

40PUBLICATIONS
214CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical genetics (excl. cancer genetics)Medical mycologyPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Sep 02, 2026
Teclistamab and Daratumumab Immune-Based Doublet Therapy for Relapsed/Refractory Multiple Myeloma: the TRIMM-2 Study.

|Jul 25, 2026
Autologous stem cell transplantation in POEMS syndrome: Multicenter real-world treatment patterns and outcomes.

|Jul 24, 2026
MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma.

|Jul 17, 2026
Study of post-translational modifications of p53 in multiple myeloma.

|Apr 06, 2026
Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial.

Francesca Gay, Wilfried Roeloffzen, Meletios A Dimopoulos

|Jan 29, 2026
Immune biomarkers of increased infection risk in multiple myeloma.

Aintzane Zabaleta, Luis-Esteban Tamariz-Amador, Ioannis V Kostopoulos

Pageof 7

Frequent Collaborators

24 joint publications

María-Victoria Mateos

23 joint publications

Jesus San-Miguel

21 joint publications

Laura Rosiñol

20 joint publications

Juan-José Lahuerta